Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Clinical trial NCT04334993 · UNKNOWN
Trial details
- NCT number
- NCT04334993
- Sponsor
- Israeli Medical Association
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.